VIRGINIA RETIREMENT SYSTEMS ET Al Takes $3.87 Million Position in National Health Investors, Inc. $NHI

Key Points

• Virginia Retirement Systems acquired a new stake in National Health Investors, Inc., purchasing 55,200 shares valued at approximately $3.87 million during the second quarter.
• National Health Investors reported earnings per share (EPS) of $1.22, surpassing analysts' expectations, with revenue slightly below estimates at $70.27 million for the quarter.
• The company has recently increased its quarterly dividend to $0.92 per share, resulting in an annualized yield of 4.8%.

VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in National Health Investors, Inc. (NYSE:NHI - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 55,200 shares of the real estate investment trust's stock, valued at approximately $3,871,000. VIRGINIA RETIREMENT SYSTEMS ET Al owned about 0.12% of National Health Investors at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of NHI. MetLife Investment Management LLC boosted its stake in shares of National Health Investors by 706.6% in the 1st quarter. MetLife Investment Management LLC now owns 213,730 shares of the real estate investment trust's stock valued at $15,786,000 after purchasing an additional 187,233 shares during the last quarter. Bowen Hanes & Co. Inc. bought a new position in shares of National Health Investors in the 1st quarter valued at about $10,340,000. Nuveen LLC bought a new position in shares of National Health Investors in the 1st quarter valued at about $10,126,000. Centersquare Investment Management LLC boosted its stake in shares of National Health Investors by 25.7% in the 1st quarter. Centersquare Investment Management LLC now owns 495,971 shares of the real estate investment trust's stock valued at $36,632,000 after purchasing an additional 101,538 shares during the last quarter. Finally, Jane Street Group LLC boosted its stake in National Health Investors by 1,728.4% during the 1st quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust's stock worth $5,148,000 after acquiring an additional 65,885 shares during the last quarter. Institutional investors own 62.51% of the company's stock.

National Health Investors Price Performance

NYSE NHI opened at $76.21 on Tuesday. The company has a market capitalization of $3.62 billion, a PE ratio of 24.35, a price-to-earnings-growth ratio of 3.44 and a beta of 0.77. National Health Investors, Inc. has a 12-month low of $65.13 and a 12-month high of $82.32. The firm's 50 day moving average is $77.09 and its 200-day moving average is $74.13. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75.

National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, topping analysts' consensus estimates of $1.16 by $0.06. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The firm had revenue of $70.27 million during the quarter, compared to analysts' expectations of $86.46 million. During the same period in the previous year, the business posted $1.18 earnings per share. The company's revenue for the quarter was up 6.7% compared to the same quarter last year. Equities research analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 4.8%. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. The ex-dividend date of this dividend is Tuesday, September 30th. National Health Investors's dividend payout ratio (DPR) is presently 117.57%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on NHI shares. Wells Fargo & Company lifted their price objective on shares of National Health Investors from $76.00 to $80.00 and gave the stock an "equal weight" rating in a research note on Wednesday, August 27th. National Bankshares set a $90.00 price objective on shares of National Health Investors in a research note on Wednesday, October 1st. Truist Financial lifted their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the stock a "buy" rating in a research note on Friday, August 15th. Weiss Ratings reissued a "buy (b-)" rating on shares of National Health Investors in a research note on Wednesday, October 8th. Finally, Wedbush raised shares of National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, National Health Investors currently has a consensus rating of "Buy" and a consensus price target of $84.83.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.